National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. 2020 Focused Updates to the Asthma Management Guidelines. NHLBI. NIH. [Internet] EE. UU. 2020. Disponible en https://www.nhlbi.nih.gov/resources/2020-focused-updates-asthma-management-guidelines
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2024. Actualizado mayo de 2024. Disponible en: www.ginasthma.org
Szefler SJ, et al. Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 phenotype. J Allergy Clin Immunol Pract. 2019;7(7):2286-2295.e4.
Szefler SJ, et al. A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma.J Allergy Clin Immunol. 2017;140(5):1277-1287.
Instituto de Salud Pública. SPIRIVA® RESPIMAT®. 2,5 mcg/pulsación. Ficha de producto registrado. Ministerio de Salud, gobierno de Chile. 2024. Disponible en: https://registrosanitario.ispch.gob.cl/Ficha.aspx?RegistroISP=F-17708/24